Jared Whitlock
Reporter
Phone: 858-634-4636 Extension: 3130
Recent Stories
Executive Q&A: Joe Panetta, CEO, Biocom
Joe Panetta has served as president and CEO of Biocom since 1999. Biocom is an association for life science companies and service providers.
Co. Cuts Jobs, Sees Stock Plummet Following Weak Results
Brain Cancer Combo Didn’t Outperform Chemo
Tocagen is set to slash its workforce by 65% after its brain cancer therapy flopped in a late-stage clinical trial.
Illumina, PacificBio Extend Acquisition
San Diego Company to Provide Cash Payments in the Meantime
The deadline for Illumina Inc. to acquire Pacific Biosciences has been extended as a U.K. regulator continues to review the $1.2 billion deal.
Leadership Changes At Akcea Therapeutics Include New CEO
Ionis to Deepen Its Commitment to the Company
Akcea Therapeutics on Sept. 23 announced the departures of CEO Paula Soteropoulos, President Sarah Boyce and Chief Operating Officer Jeff Goldberg.
Some Biotech Cos. Find Advantages They Need in S.D.
Talent Pool and Area’s Research Institutions Cited By Cos. Moving
DelMar Pharmaceuticals recently joined a short list of biotechs that moved to the region this year.
Co.’s Antifungal Success May Help Other Efforts
MEDICINE: Drug May Help In Bone Marrow Transplants
Antibiotic-resistant infections grab headlines.
UCSD to Open School of Public Health
EDUCATION: It Will Aim for Greater Collaborative Efforts
UC San Diego has won approval for a school of public health that would connect its efforts in medicine, technology, data science and other fields.
DNA Printer and Tech for Improved Photosynthesis Score Funding Rounds
ZeaKal Raises $15M; SGI-DNA Takes in $25M
Two San Diego biotechs with head-turning technology recently picked up venture funding.
Pursuing ‘Untapped Biology,’ Boundless Bio Receives $46.4 Million
BIOTECH: Company Tackling ecDNA’s Role in Cancer Cells
Boundless Bio Inc. emerged Sept. 19 with $46.4 million in funding and a claim to new territory: extrachromosomal DNA.
Three Executives Out at Akcea Therapeutics
Akcea Therapeutics on Sept. 23 announced the departure of CEO Paula Soteropoulos, president Sarah Boyce and chief operating officer Jeff Goldberg.